Evolent Health
EVH
$23.07
Share price
-1.03%
Change (1 day)
-30.09%
Change (1 year)
Categories
P/S ratio for Evolent Health (EVH)
P/S ratio as of May 2024 (TTM): 1.36
According to Evolent Health's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 1.36112. At the end of 2023 the company had a P/S ratio of 1.93.
P/S ratio history for Evolent Health from 2015 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 1.93 | -8% |
| 2022 | 2.10 | -22.87% |
| 2021 | 2.72 | 91.43% |
| 2020 | 1.42 | 57.37% |
| 2019 | 0.9045 | -64.09% |
| 2018 | 2.52 | 19.26% |
| 2017 | 2.11 | -31.01% |
| 2016 | 3.06 | -40.98% |
| 2015 | 5.19 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 National Healthcare
NHC | 1.34 | -1.54% | 🇺🇸 USA |
 Global Cord Blood CORBF | 0.8635 | -36.56% | 🇭🇰 Hong Kong |
 Graham Holdings GHC | 0.7484 | -45.02% | 🇺🇸 USA |
 CryoLife CRY | N/A | N/A | 🇺🇸 USA |